Neoadjuvant endocrine therapy in breast cancer
- 28 February 2006
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 15 (1) , 9-19
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomesThe Journal of Steroid Biochemistry and Molecular Biology, 2003
- Neoadjuvant comparisons of aromatase inhibitors and tamoxifen: pretreatment determinants of response and on-treatment effectThe Journal of Steroid Biochemistry and Molecular Biology, 2003
- Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary reportThe Journal of Steroid Biochemistry and Molecular Biology, 2003
- Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapyEuropean Journal of Cancer, 2001
- Steroid hormone receptors in breast cancer managementBreast Cancer Research and Treatment, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Treatment of breast cancer in elderly patientsJournal of Surgical Oncology, 1995
- Inflammatory Breast CancerAmerican Journal of Clinical Oncology, 1993
- Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen aloneBritish Journal of Surgery, 1991
- Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.BMJ, 1982